Qin Wu

Qin Wu is a Principal Investigator at the Hangzhou Institute of Medicine, Chinese Academy of Sciences (CAS), and a Professor in the School of Molecular Medicine at the Hangzhou Institute for Advanced Study, UCAS. She received her Ph.D. in Chemical Biology from the University of Science and Technology of China and completed her postdoctoral training in Prof. Cheryl Arrowsmith's lab at the Structural Genomics Consortium, University of Toronto. Dr. Wu’s research focuses on developing cutting-edge chemical approaches to understand the mechanisms driving tumor progression, identify therapeutic targets, and discover treatment biomarkers, thereby advancing precision treatments for cancer. Dr. Wu leads the program of aptamer development and functional validation at the Hangzhou Institute of Medicine.